Arthritis psoriatica: vizsgálatok itt: Csehország
9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 4. fázisTaking peopleAn open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment
- Where
- Brno, Brno-Židenice, Hlučín, Novy Hradec Kralove, Olomouc, Prague, Prague 1, Prague 11, Prague 2, Prague 4, Praha 4, Trebovice, Uherské Hradiště
- People
- 339 worldwide
- Run by
- Novartis Pharma AG
See details and how to joinNCT04638647 · EU 2023-504417-67-00 - 2. fázisTaking peopleStudy of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
- Where
- Brno, Hlučín, Uherské Hradiště, Zlín
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- AbbVie
See details and how to joinNCT06865105 - 1. fázisTaking peopleA Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
- Where
- Brno, Hlučín, Ostrava, Uherské Hradiště
- Életkor
- 18 év and over
- People
- 392 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT07290036 - 3. fázisTaking peopleA Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
- Where
- Brno, Prague
- Életkor
- 1 év to 18 év
- People
- 190 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT03773965 - 3. fázisTaking peopleA Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- Where
- Brno-Sever, Hlučín, Moravska Ostrava A Privoz, Pardubice I, Prague, Prague 10, Prague 2, Uherské Hradiště, Zlín
- Életkor
- 18 év and over
- People
- 1088 worldwide
- Run by
- Takeda
See details and how to joinNCT06671483 · EU 2024-513111-27-00 - 3. fázisTaking peopleA Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
- Where
- Olomouc, Prague
- Életkor
- 5 év to 17 év
- People
- 60 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06869551 · EU 2024-517262-41-00 - 3. fázisTaking peopleContinuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- Where
- Brno-Sever, Hlučín, Moravska Ostrava A Privoz, Pardubice I, Prague, Prague 10, Prague 2, Uherské Hradiště, Zlín
- Életkor
- 18 év and over
- People
- 1182 worldwide
- Run by
- Takeda
See details and how to joinNCT07286058 · EU 2025-522586-30-00 - 3. fázisNot yet taking people in CsehországA study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with psoriatic arthritis (PsA)
- Where
- Břeclav, Brno-Sever, Butovice, Moravska Ostrava A Privoz, Prague, Prague 11, Prague 2, Praha 4, Praha 4-Krc, Zlín
- Életkor
- 18 év and over
- People
- 948 worldwide
- Run by
- MoonLake Immunotherapeutics AG
See details and how to join2025-522471-28-00 · EU 2025-522471-28-00 - No phaseTaking peopleAn Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
- Where
- Ostrava, Pilsen
- Életkor
- 18 év to 75 év
- People
- 1200 worldwide
- Run by
- AbbVie
See details and how to joinNCT06764693